Avotaciclib trihydrochloride

(Synonyms: BEY1107 trihydrochloride)
3 Cited Publications
Customer Review

Based on 3 publication(s) in Google Scholar

Avotaciclib (BEY1107) trihydrochloride is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. Avotaciclib trihydrochloride can inhibit the proliferation and induce apoptosis of tumor cells. Avotaciclib trihydrochloride can be used in the research of cancer such as pancreatic cancer and lung cancer.

For research use only. We do not sell to patients.

  • Purity: 99.60%
  • CAS No.: 1983984-01-5
  • Formula: C13H14Cl3N7O
  • Molecular Weight:390.66
  • Storage:

    4°C, sealed storage, away from moisture and light

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00